Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation [Phase 2]
A completed Phase 2 trial evaluating beta-hydroxy-beta-methylbutyrate (HMB) to counteract muscle loss in men with prostate cancer receiving …
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 study of AZD8186, a PI3K-β inhibitor, in combination with docetaxel for patients with PTEN or PIK3CB-mutant advanced solid tumors, i…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Study of 18F-Thretide PET/CT in Patients With Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial assessing 18F-Thretide PET/CT imaging in patients with prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Postoperative Pain in Laparoscopic Radical Prostatectomy Surgery With Tranexamic Acid: Analgesia? Hiperalgesia? [Phase 4]
A Phase 4 clinical trial update exploring postoperative pain management after laparoscopic radical prostatectomy using tranexamic acid for a…
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy [Phase 1, Phase 2]
A clinical trial evaluating ipatasertib or apitolisib with abiraterone acetate versus abiraterone alone in previously treated castration-res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-09-05Clinical Trial Update: Non-systemic Treatment for Patients With Low-volume Metastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating a non-systemic treatment for patients with low-volume metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-23Clinical Trial Update: Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial update for HRS-4357 in patients with advanced prostate cancer.
-
CLINICAL_TRIALS trial_result · 2023-08-22Clinical Trial Update: Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer [Phase 2]
Phase 2 clinical trial assessing dutasteride's effect on androgen-response gene expression in patients with advanced prostate cancer has com…
-
CLINICAL_TRIALS trial_result · 2023-08-22Clinical Trial Update: Soccer Intervention in Prostate Cancer Survivors [NA]
Completed clinical trial evaluating a soccer intervention for prostate cancer survivors; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Prostate Medication, Metabolism and Gut Microbiota [Phase 4]
Phase 4 clinical trial update investigating a prostate medication's metabolism and gut microbiota effects in prostatic hyperplasia and prost…
-
CLINICAL_TRIALS trial_result · 2023-08-18Clinical Trial Update: Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating radiation therapy with androgen suppression in patients with prostate cancer.
-
CLINICAL_TRIALS trial_result · 2023-08-18Clinical Trial Update: Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer [Phase 2]
Phase 2 trial comparing hypofractionated whole-pelvis radiotherapy to conventionally-fractionated radiotherapy in prostate cancer is active …
-
CLINICAL_TRIALS trial_result · 2023-08-09Clinical Trial Update: Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPC [Phase 3]
Phase 3 trial comparing rezvilutamide with ADT and docetaxel versus rezvilutamide with ADT in metastatic hormone-sensitive prostate cancer i…
-
CLINICAL_TRIALS trial_result · 2023-08-07Clinical Trial Update: A Phase 2 Trial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate Cancer [Phase 2]
Phase 2 trial exploring darolutamide as a PSMA expression enhancer in localized prostate cancer.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer [Phase 2]
Phase 2 trial evaluating Reolysin with docetaxel and prednisone versus docetaxel and prednisone alone in metastatic castration-resistant pro…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer [Phase 3]
Phase 3 trial investigating androgen suppression and radiation with or without docetaxel in high-risk localized prostate cancer was terminat…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy [Phase 2]
Phase 2 clinical trial evaluating docetaxel and prednisone with or without OGX-011 in recurrent or metastatic prostate cancer after progress…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Study to Compare the Effects of Drug Darolutamide and Drug Enzalutamide on Physical Function, Including Balance and Daily Activity, in Patients With Castration-resistant Prostate Cancer (CRPC) [Phase 2]
Phase 2 trial comparing darolutamide and enzalutamide in castration-resistant prostate cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: SB939 in Treating Patients With Recurrent or Metastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial update for SB939 in recurrent or metastatic prostate cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer [Phase 2]
Phase 2 trial update evaluating sorafenib in metastatic or recurrent prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene [Phase 1, Phase 2]
Phase 1/2 clinical trial studying A166 in patients with various HER2-expressing or HER2-amplified cancers has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-02Clinical Trial Update: Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer. [Phase 2]
Phase 2 study evaluating efficacy, safety, and quality of life after VTP treatment with TOOKAD Soluble for intermediate-risk prostate cancer…
-
CLINICAL_TRIALS trial_result · 2023-08-02Clinical Trial Update: FACBC Outcomes for Post Prostatectomy [Phase 2, Phase 3]
Phase 2/3 clinical trial update on FACBC for prostate cancer after prostatectomy has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-02Clinical Trial Update: Decision Aids to Improve Knowledge in Patients With Prostate Cancer [NA]
Completed clinical trial evaluating decision aids to improve knowledge in patients with prostate cancer; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Leuprolide Acetate 3.75 mg Depot Injection for Patients With Advanced Prostate Cancer [Phase 3]
A Phase 3 trial update for Leuprolide Acetate 3.75 mg Depot Injection in advanced prostate cancer has completed.